IBDEI0TG ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14529,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14529,1,4,0)
 ;;=4^793.11
 ;;^UTILITY(U,$J,358.3,14529,1,5,0)
 ;;=5^Abn Chest Xray, Lung, Solitary Nodule
 ;;^UTILITY(U,$J,358.3,14529,2)
 ;;=^340570
 ;;^UTILITY(U,$J,358.3,14530,0)
 ;;=793.19^^89^894^2
 ;;^UTILITY(U,$J,358.3,14530,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14530,1,4,0)
 ;;=4^793.19
 ;;^UTILITY(U,$J,358.3,14530,1,5,0)
 ;;=5^Abn Chest Xray,Oth Finding, Lung
 ;;^UTILITY(U,$J,358.3,14530,2)
 ;;=^340571
 ;;^UTILITY(U,$J,358.3,14531,0)
 ;;=795.51^^89^894^32
 ;;^UTILITY(U,$J,358.3,14531,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14531,1,4,0)
 ;;=4^795.51
 ;;^UTILITY(U,$J,358.3,14531,1,5,0)
 ;;=5^Pos PPD w/o Active TB
 ;;^UTILITY(U,$J,358.3,14531,2)
 ;;=^340572
 ;;^UTILITY(U,$J,358.3,14532,0)
 ;;=795.52^^89^894^31
 ;;^UTILITY(U,$J,358.3,14532,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14532,1,4,0)
 ;;=4^795.52
 ;;^UTILITY(U,$J,358.3,14532,1,5,0)
 ;;=5^Pos GMA Interferon w/o Active TB
 ;;^UTILITY(U,$J,358.3,14532,2)
 ;;=^340573
 ;;^UTILITY(U,$J,358.3,14533,0)
 ;;=V15.82^^89^894^21
 ;;^UTILITY(U,$J,358.3,14533,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14533,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,14533,1,5,0)
 ;;=5^H/O Tobacco Abuse
 ;;^UTILITY(U,$J,358.3,14533,2)
 ;;=^303405
 ;;^UTILITY(U,$J,358.3,14534,0)
 ;;=511.89^^89^894^27
 ;;^UTILITY(U,$J,358.3,14534,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14534,1,4,0)
 ;;=4^511.89
 ;;^UTILITY(U,$J,358.3,14534,1,5,0)
 ;;=5^Pleural Effusion NEC
 ;;^UTILITY(U,$J,358.3,14534,2)
 ;;=^336604
 ;;^UTILITY(U,$J,358.3,14535,0)
 ;;=511.9^^89^894^28
 ;;^UTILITY(U,$J,358.3,14535,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14535,1,4,0)
 ;;=4^511.9
 ;;^UTILITY(U,$J,358.3,14535,1,5,0)
 ;;=5^Pleural Effusion NOS
 ;;^UTILITY(U,$J,358.3,14535,2)
 ;;=^123973
 ;;^UTILITY(U,$J,358.3,14536,0)
 ;;=376.01^^89^895^25
 ;;^UTILITY(U,$J,358.3,14536,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14536,1,4,0)
 ;;=4^376.01
 ;;^UTILITY(U,$J,358.3,14536,1,5,0)
 ;;=5^Orbital Cellulitis
 ;;^UTILITY(U,$J,358.3,14536,2)
 ;;=^259068
 ;;^UTILITY(U,$J,358.3,14537,0)
 ;;=388.70^^89^895^26
 ;;^UTILITY(U,$J,358.3,14537,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14537,1,4,0)
 ;;=4^388.70
 ;;^UTILITY(U,$J,358.3,14537,1,5,0)
 ;;=5^Otalgia, Unsp
 ;;^UTILITY(U,$J,358.3,14537,2)
 ;;=^37811
 ;;^UTILITY(U,$J,358.3,14538,0)
 ;;=380.10^^89^895^27
 ;;^UTILITY(U,$J,358.3,14538,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14538,1,4,0)
 ;;=4^380.10
 ;;^UTILITY(U,$J,358.3,14538,1,5,0)
 ;;=5^Otitis Externa,Infect
 ;;^UTILITY(U,$J,358.3,14538,2)
 ;;=^62807
 ;;^UTILITY(U,$J,358.3,14539,0)
 ;;=381.01^^89^895^31
 ;;^UTILITY(U,$J,358.3,14539,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14539,1,4,0)
 ;;=4^381.01
 ;;^UTILITY(U,$J,358.3,14539,1,5,0)
 ;;=5^Otitis Media, Serous Acute
 ;;^UTILITY(U,$J,358.3,14539,2)
 ;;=^269369
 ;;^UTILITY(U,$J,358.3,14540,0)
 ;;=382.9^^89^895^28
 ;;^UTILITY(U,$J,358.3,14540,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14540,1,4,0)
 ;;=4^382.9
 ;;^UTILITY(U,$J,358.3,14540,1,5,0)
 ;;=5^Otitis Med, Other Acute
 ;;^UTILITY(U,$J,358.3,14540,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,14541,0)
 ;;=382.01^^89^895^30
 ;;^UTILITY(U,$J,358.3,14541,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14541,1,4,0)
 ;;=4^382.01
 ;;^UTILITY(U,$J,358.3,14541,1,5,0)
 ;;=5^Otitis Media W/Tympanic Membrane Rupture
 ;;^UTILITY(U,$J,358.3,14541,2)
 ;;=^269396
 ;;^UTILITY(U,$J,358.3,14542,0)
 ;;=381.10^^89^895^29
 ;;^UTILITY(U,$J,358.3,14542,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14542,1,4,0)
 ;;=4^381.10
 ;;^UTILITY(U,$J,358.3,14542,1,5,0)
 ;;=5^Otitis Med, Serous Chronic
